Last reviewed · How we verify
NCT06848270
Effectiveness of Early Intervention in Palliative Care for Acute Myeloid Leukemia Patients Comparing to Standard of Care
NA trial testing Early palliative care integration in Palliative Care in 50 participants. Not yet recruiting.
31 July 2026
Quick facts
| Lead sponsor | Universidade do Porto |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 50 |
| Start date | 1 April 2025 |
| Primary completion | 31 July 2026 |
| Estimated completion | 1 August 2026 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Early palliative care integration — full drug profile →
Conditions studied
- Palliative Care — all drugs for Palliative Care →
- Acute Myeloid Leukaemia — all drugs for Acute Myeloid Leukaemia →
Sponsor
Universidade do Porto — full company profile →
Who can join
Under 70, any sex, with Palliative Care or Acute Myeloid Leukaemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hemato-oncology patients undergoing intensive chemotherapy treatments experience different types of symptoms during and after treatments, which are often refractory to the established therapy. Physical symptoms such as pain, dyspnea, mucositis, insomnia, loss of appetite, constipation and diarrhea, among others, have a huge impact on quality of life, temporarily until symptomatic control, but also permanently with the development of anxiety, depression, long-term fatigue and post-traumatic stress. As recommended by ASCO (American Society of Clinical Oncology), the palliative approach to oncological diseases must be as early as possible and be part of the "standard of care". However, the lack of concrete data on this topic in the last decade served as a barrier to the early integration of this same care for hemato-oncology patients in its various areas. Palliative care presupposes global, interdisciplinary action, carried out by specific teams that must act in situations of incurable or serious illness, in an advanced and progressive phase. The potential benefits can be countless and of significant importance, from the impact on quality of life, symptomatic control, reduction of anxiety and depression and even the promotion of informed and conscious choices at the end of life as well as the reduction of aggressive strategies. used at this stage of the disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06848270
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Early palliative care integration
Trials testing the same drug.
- NCT03800095 — Early Palliative Care for Patients With Haematological Malignancies · Phase 3 · unknown
- NCT06726317 — Early Palliative Care For Patients With Oral Cancer in Sri Lanka · NA · completed
Other recruiting trials for Palliative Care
Currently open trials in the same condition.
- NCT07505706 — Patient Journey in Palliative Care Within the NOVO Hospital Group. · active not recruiting
- NCT07469761 — MultidISciplinary Care paThway tailoRed on frAilty in Cancer Patients Referred to Outpatient paLliative Care · NA · recruiting
- NCT06588556 — Improving Needs Among Older Adults · NA · recruiting
- NCT07109050 — Virtual Reality Within Palliative Care (VR-SPC) · NA · recruiting
- NCT06771999 — Attitudes Towards Deprescribing Medications in Cancer Patients and Impact of Educational Intervention by a Clinical Phar · NA · recruiting
Other Universidade do Porto trials
Trials by the same sponsor.
- NCT07457697 — MyGENESIS: A Digital Psychoeducational Program for Donor-Conceived Young Adults · NA · not yet recruiting
- NCT07503990 — Effects of Food Intake Sequence on Substrate Utilisation and Endurance Performance · NA · recruiting
- NCT07436091 — Porcine Derma for Soft Tissue Augmentation Around Implants · NA · not yet recruiting
- NCT07498556 — Immediate Restoration of a New Implant With High Primary Stability · NA · not yet recruiting
- NCT07448870 — Evaluating the Mentalization-based Treatment Lighthouse Parenting Programme: Protocol of a Feasibility and Acceptability · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06848270 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade do Porto
- Last refreshed: 27 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06848270.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing